Live tape
CellLight-directed evolution of dynamic, multi-state, and computational protein functionalitiesCellSelective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosisCellDynamics of natural selection preceding human viral epidemics and pandemicsCellDeltaviruses spread through a viral Trojan HorseCellβ-hydroxybutyrate enhances the metabolic fitness of CAR T cells in cancerIlluminaAssessing Illumina (ILMN) Valuation After Recent Share Price Weakness - simplywall.stLonza NewsWill Lonza Group AG (Common Stock) (LO3A) stock beat growth indexes - Short Setup & Smart Investment Allocation Tips - Naître et grandirThermo FisherNeo Ivy Capital Management Buys 3,865 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeatIlluminaNeo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeatEndpoints NewsUniQure’s dispute with FDA; Zealand’s obesity readout; China takes on world’s most expensive medicines; and moreWatersRep. Kevin Hern Shares of Waters Corporation (NYSE:WAT) - MarketBeatLonza NewsLonza sells off its capsules division to British firm - SWI swissinfo.ch
Archive

A tighter archive for life-science signals.

Search once, then narrow by source or topic.

Latest first Oldest first Clear filters
Active source Lonza News
All stories 241
Active source Lonza News
Active query Lonza
Lonza News Oct 7, 2025

Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire

Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk...

#Therapeutic Innovations #Forecast Report #Featuring Lonza #Novo Nordisk
Directory ribbon

Brand directory, kept in view

A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.

Open about page